
Xtalks Webinars
@xtalks
Provides insight on Life Science issues (#Pharma, #Biotech, #MedicalDevice) via breaking news & interactive webinars with industry experts
ID: 136013508
http://www.xtalks.com 22-04-2010 20:12:26
17,17K Tweet
26,26K Takipçi
15,15K Takip Edilen


To mark World AIDS Vaccine Day 2025 on Sunday, May 18, explore the latest clinical trial updates, delivery innovations and affordability models — along with real-world barriers to HIV treatment access — at buff.ly/R4Gpqat by Soumya Shashikumar.


Abeona’s Zevaskyn has received FDA approval for the rare skin disease RDEB, becoming the first and only cell-based gene therapy approved for the condition. Read more at buff.ly/2fzvhbP by Ayesha Rashid about the treatment, which is described as a cell sheet-based gene

The FDA just expanded unannounced inspections to foreign facilities. Our latest article breaks down why, what’s changing and how this may impact quality control abroad. Learn more at buff.ly/wWIALBu by Soumya Shashikumar.

Learn how digital tools can streamline clinical study operations and make trials more participant-friendly, with insights from Studypages’ Koen De Lombaert, MD. MBA, and Eron Villarreal. Watch the Spotlight video and read more at buff.ly/YHIhhdR by Vera Kovacevic.



Discover how OncoC4 and its founder Dr. Yang Liu are redefining cancer treatment through precision immunotherapies that target the tumor microenvironment and novel immune checkpoints. Read more in our Xtalks Clinical Edge™ feature at buff.ly/fkfkEkf by Vera Kovacevic.


The EU is investing €500 million (roughly $537 million) into scientific research in Europe through its new “Choose Europe for Science” campaign. Read more at buff.ly/FeQJABR by Ayesha Rashid about the program, which aims to attract and support top researchers from around

Amid Trump’s tariff threats on drug imports, big pharma is doubling down on its US presence, with BMS announcing an investment of $40B over 5 years and Gilead committing $11B in fresh US investments. Read more at buff.ly/Upw8JxT by Ayesha Rashid.


Teal Health’s Teal Wand has received FDA approval as the first at-home self-collection device for cervical cancer screening in the US. Read more at buff.ly/45ZjQ1h by Ayesha Rashid about the tool, which offers a convenient alternative to traditional in-clinic Pap smears.

The FDA just approved three new natural food colorings — including algae-derived blue and mineral-based white. Read how these pigments could shape clean-label strategies at buff.ly/F1Il2jt by Soumya Shashikumar.






US president Trump’s 2026 budget plan proposes major cuts to healthcare and social programs, while boosting defense and border security spending. Read more at buff.ly/vAuEbAH by Ayesha Rashid about the proposed budget, which includes billion-dollar funding cuts to health